Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
Journal
-
- Frontiers in Immunology
-
Frontiers in Immunology 9 2018-04-19
Frontiers Media SA
- Tweet
Details 詳細情報について
-
- CRID
- 1360576121867786112
-
- ISSN
- 16643224
-
- Data Source
-
- Crossref